350 related articles for article (PubMed ID: 25791893)
1. Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy.
Sheinberg R; Heyman E; Dagan Z; Youngster I; Kohn E; Gandelman-Marton R; Berkovitch M
Pediatr Neurol; 2015 Jun; 52(6):624-8. PubMed ID: 25791893
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy.
Muramatsu K; Sawaura N; Ogata T; Makioka N; Tomita K; Motojima T; Ida K; Hazama K; Arakawa H
Brain Dev; 2017 Mar; 39(3):231-235. PubMed ID: 27745925
[TBL] [Abstract][Full Text] [Related]
4. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
5. Intravenous levetiracetam in children with seizures: a prospective safety study.
Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
Li S; Cao J; Xiao N; Cai F
J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.
Grosso S; Cordelli DM; Franzoni E; Coppola G; Capovilla G; Zamponi N; Verrotti A; Morgese G; Balestri P
Seizure; 2007 Jun; 16(4):345-50. PubMed ID: 17368928
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
Krief P; Li Kan ; Maytal J
J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
[TBL] [Abstract][Full Text] [Related]
11. Retrospective study of the use of levetiracetam in childhood seizure disorders.
Koukkari MW; Guarino EJ
J Child Neurol; 2004 Dec; 19(12):944-7. PubMed ID: 15704867
[TBL] [Abstract][Full Text] [Related]
12. An initial experience with therapeutic drug monitoring of levetiracetam as reported from a pediatric clinical setting in India.
Mathew BS; Fleming DH; Thomas M; Prabha R; Saravanakumar K
Neurol India; 2012; 60(2):146-9. PubMed ID: 22626693
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
Perry S; Holt P; Benatar M
J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy.
Grosso S; Franzoni E; Coppola G; Iannetti P; Verrotti A; Cordelli DM; Marchiani V; Pascotto A; Spalice A; Acampora B; Morgese G; Balestri P
Seizure; 2005 Jun; 14(4):248-53. PubMed ID: 15911359
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience.
Tan MJ; Appleton RE
Seizure; 2004 Apr; 13(3):142-5. PubMed ID: 15010050
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
Tonekaboni SH; Ghazavi M; Karimzadeh P; Mahvelati F; Ghofrani M
Epilepsy Res; 2010 Aug; 90(3):273-7. PubMed ID: 20619606
[TBL] [Abstract][Full Text] [Related]
18. [Experience with levetiracetam in childhood epilepsy].
Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam in refractory pediatric epilepsy.
Wheless JW; Ng YT
J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
Obeid M; Pong AW
Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
